Kimberly A. Gudzune

Kimberly A. Gudzune

Auto-generated profile, based on publicly available information

Kimberly A. Gudzune

Johns Hopkins University School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2015 in Annals of Internal Medicine
Verified
Journal Article
Closed access
KGKimberly A. Gudzune
Kimberly A. Gudzune
RDRuchi S. Doshi
Ruchi S. Doshi
AMAmbereen K. Mehta
Ambereen K. Mehta
ZCZoobia W. Chaudhry
Zoobia W. Chaudhry
DJDavid K. Jacobs
David K. Jacobs
JCJeanne M. Clark
Jeanne M. Clark
Commercial and proprietary weight-loss programs are popular options for obesity treatment, but their efficacy is unclear. This systematic review examined the benefits, adherence, and harms of comme... This article has been corrected. The original version (PDF) is appended to this article as a Supplement. Background: Commercial and proprietary weight-loss programs are popular obesity treatment op...

20 March 2013 in Obesity
Verified
Journal Article
Open access
PDF file
KGKimberly A. Gudzune
Kimberly A. Gudzune
MBMary Catherine Beach
Mary Catherine Beach
DRDebra L. Roter
Debra L. Roter
LCLisa A. Cooper
Lisa A. Cooper
Objective: Physicians' negative attitudes toward patients with obesity are well documented. Whether or how these beliefs may affect patient–physician communication is unknown. To describe the relationship between patient body mass index (BMI) and physician communication behaviors (biomedical, psychosocial/lifestyle, and rapport building) during typical outpatient primary care visits was aimed.Design and Methods: Using audio‐recorded outpatient encounters from 39 urban primary care physicians (PCPs) and 208 of their patients, the frequency of communication behaviors using the Roter Interaction Analysis System was examined. The independent variable was measured; patient BMI and dependent variables were communication behaviors by the PCP within the biomedical, psychosocial/lifestyle, and rapport building domains. A cross‐sectional analysis using multilevel Poisson regression models to evaluate the association between BMI and physician communication was performed.Results: PCPs demonstrated less emotional rapport with overweight and obese patients (incidence rate ratio, IRR, 0.65, 95%CI 0.48‐0.88, P = 0.01; IRR 0.69, 95%CI 0.58‐0.82, P < 0.01, respectively) than for normal weight patients. No differences in PCPs' biomedical or psychosocial/lifestyle communication by patient BMI were found.Conclusions: Our findings raise the concern that low levels of emotional rapport in primary care visits with overweight and obese patients may weaken the patient–physician relationship, diminish patients' adherence to recommendations, and decrease the effectiveness of behavior change counseling.

1 October 2014 in Patient Education and Counseling
Verified
Journal Article
Closed access
KGKimberly A. Gudzune
Kimberly A. Gudzune
WBWendy L Bennett
Wendy L Bennett
LCLisa A. Cooper
Lisa A. Cooper
SBSara N. Bleich
Sara N. Bleich

1 May 2014 in Preventive Medicine
Verified
Journal Article
Closed access
KGKimberly A. Gudzune
Kimberly A. Gudzune
WBWendy L Bennett
Wendy L Bennett
LCLisa A. Cooper
Lisa A. Cooper
SBSara N. Bleich
Sara N. Bleich

21 March 2013 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
KGKimberly A. Gudzune
Kimberly A. Gudzune
MHMary M. Huizinga
Mary M. Huizinga
HCHsien-Yen Chang
Hsien-Yen Chang
VAVivian Asamoah
Vivian Asamoah
MGMeghana Gadgil
Meghana Gadgil
JCJeanne M. Clark
Jeanne M. Clark

1 April 2014 in Annals of Internal Medicine
Verified
Journal Article
Open access
PDF file
KGKimberly A. Gudzune
Kimberly A. Gudzune
AMAnne K. Monroe
Anne K. Monroe
RSRitu Sharma
Ritu Sharma
PRPadmini D. Ranasinghe
Padmini D. Ranasinghe
YCYohalakshmi Chelladurai
Yohalakshmi Chelladurai
KRKaren A. Robinson
Karen A. Robinson
Background: Some patients do not tolerate or respond to high-intensity statin monotherapy. Lower-intensity statin combined with nonstatin medication may be an alternative, but the benefits and risks compared with those of higher-intensity statin monotherapy are unclear. Purpose: To compare the clinical benefits, adherence, and harms of lower-intensity statin combination therapy with those of higher-intensity statin monotherapy among adults at high risk for atherosclerotic cardiovascular disease (ASCVD). Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to July 2013, with an updated MEDLINE search through November 2013. Study Selection: Randomized, controlled trials published in English. Data Extraction: Two reviewers extracted information on study design, population characteristics, interventions, and outcomes (deaths, ASCVD events, low-density lipoprotein [LDL] cholesterol level, adherence, and adverse events). Two independent reviewers assessed risk of bias. Data Synthesis: A total of 36 trials were included. Low-intensity statin plus bile acid sequestrant decreased LDL cholesterol level 0% to 14% more than mid-intensity monotherapy among high-risk hyperlipidemic patients. Mid-intensity statin plus ezetimibe decreased LDL cholesterol level 5% to 15% and 3% to 21% more than high-intensity monotherapy among patients with ASCVD and diabetes mellitus, respectively. Evidence was insufficient to evaluate LDL cholesterol for fibrates, niacin, and ω-3 fatty acids. Evidence was insufficient for long-term clinical outcomes, adherence, and harms for all regimens. Limitation: Many trials had short durations and high attrition rates, lacked blinding, and did not assess long-term clinical benefits or harms. Conclusion: Clinicians could consider using lower-intensity statin combined with bile acid sequestrant or ezetimibe among high-risk patients intolerant of or unresponsive to statins; however, this strategy should be used with caution given the lack of evidence on long-term clinical benefits and harms. Primary Funding Source: Agency for Healthcare Research and Quality.